General meetings

April 26, 2021

Annual General Meeting

Date: April 26, 2021 1:00 pm
Where: Digital participation

May 20, 2020

Extraordinary General meeting

Date: May 20, 2020 2:30 pm
Where: Digital participation / Gullhaugveien 7, Oslo

April 22, 2020

Annual General Meeting

Date: April 22, 2020 12:00 pm
Where: Gullhaugveien 7, Oslo (Office of Oncoinvent AS)

April 30, 2019

Annual General Meeting

Date: April 30, 2019 3:00 pm
Where: Radisson Blu Nydalen

April 24, 2018

Annual General Meeting

Date: April 24, 2018 3:00 pm
Where: Radisson Blue Nydalen

March 14, 2017

Annual General Meeting

Date: March 14, 2017 3:00 pm
Where: Radisson Blu Nydalen

Jan Alan Alfheim

Chief Executive Officer

+47 464 40 045

Jan A. Alfheim is a business executive with over thirty years’ experience bringing product ideas and technology to the chemical and pharmaceutical markets, from product concept inception through discovery and development phases to final marketing campaign and launch.

With experience in research, project management, business development & partnering, company start-ups, and product launches, Alfheim comes from Nordic Nanovector ASA where he was Chief Executive Officer from 2011 until 2014 and Chief Operating Officer from 2014 to 2016. Prior to working at Nordic Nanovector, he has held various senior roles including Chief Business Officer at Clavis Pharma, President of StemPath Inc, Director of Business Development at Neurochem Inc and Project Director at Nycomed Imaging. Mr. Alfheim holds a MSc from Concordia University and a MBA from McGill University.